These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19434487)

  • 1. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.
    Esbensen AJ; Greenberg JS; Seltzer MM; Aman MG
    J Autism Dev Disord; 2009 Sep; 39(9):1339-49. PubMed ID: 19434487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
    Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
    Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine: diverse use in pharmacologic management.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2011 Apr; 47(2):105-8. PubMed ID: 21426356
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychiatric comorbidity and medication use in adults with autism spectrum disorder.
    Buck TR; Viskochil J; Farley M; Coon H; McMahon WM; Morgan J; Bilder DA
    J Autism Dev Disord; 2014 Dec; 44(12):3063-71. PubMed ID: 24958436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism.
    Tsakanikos E; Costello H; Holt G; Sturmey P; Bouras N
    J Autism Dev Disord; 2007 Jul; 37(6):1080-5. PubMed ID: 17053989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
    Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.
    Murray ML; Hsia Y; Glaser K; Simonoff E; Murphy DG; Asherson PJ; Eklund H; Wong IC
    Psychopharmacology (Berl); 2014 Mar; 231(6):1011-21. PubMed ID: 23681164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.
    Rosenberg RE; Mandell DS; Farmer JE; Law JK; Marvin AR; Law PA
    J Autism Dev Disord; 2010 Mar; 40(3):342-51. PubMed ID: 19806445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
    Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
    Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Child, parent, and service predictors of psychotropic polypharmacy among adolescents and young adults with an autism spectrum disorder.
    Lake JK; Weiss JA; Dergal J; Lunsky Y
    J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):486-93. PubMed ID: 25329798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parent-assisted friendship training for children with autism spectrum disorders: effects of psychotropic medication.
    Frankel F; Myatt R; Feinberg D
    Child Psychiatry Hum Dev; 2007 Apr; 37(4):337-46. PubMed ID: 17406973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: perspective from a developing country.
    Memari AH; Ziaee V; Beygi S; Moshayedi P; Mirfazeli FS
    Res Dev Disabil; 2012; 33(2):563-9. PubMed ID: 22119705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
    Alfageh BH; Man KKC; Besag FMC; Alhawassi TM; Wong ICK; Brauer R
    J Autism Dev Disord; 2020 Feb; 50(2):625-633. PubMed ID: 31724119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.
    Martin A; Scahill L; Klin A; Volkmar FR
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):923-31. PubMed ID: 10405512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
    Bachmann CJ; Manthey T; Kamp-Becker I; Glaeske G; Hoffmann F
    Res Dev Disabil; 2013 Sep; 34(9):2551-63. PubMed ID: 23747941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic medication use in children with autism in the Kentucky Medicaid population.
    Williams PG; Woods C; Stevenson M; Davis DW; Radmacher P; Smith M
    Clin Pediatr (Phila); 2012 Oct; 51(10):923-7. PubMed ID: 22492834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
    Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
    J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.